Key Dates

Related Announcements

RFA-DA-23-057 - HEAL Initiative: HEAL Data2Action - Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)

RFA-DA-23-058 - HEAL Initiative: HEAL Data2Action - Acceleration Projects (R33 Clinical Trial Not Allowed)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants that the Division of Epidemiology, Services, and Prevention Research (DESPR) at the National Institute on Drug Abuse (NIDA) will host a pre-application webinar on Wednesday, October 12, 2022, from 1:00 p.m. to 2:30 p.m. (Eastern Daylight Time, EDT) for those interested in learning more about RFA-DA-23-057 HEAL Initiative: HEAL Data2Action - Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) and RFA-DA-23-058 HEAL Initiative: HEAL Data2Action - Acceleration Projects (R33 Clinical Trial Not Allowed) . Staff from NIDA and the other institutes participating in the RFA (the National Center for Complementary and Integrative Health NCCIH and the National Institute on Alcohol Abuse and Alcoholism NIAAA) will review RFA-DA-23-057 and RFA-DA-23-058 and answer questions from prospective applicants. Details on how to attend and submit questions will soon be available on the NIDA Meetings and Events page

Participation in the webinar is not required to submit an application. We plan to post a recording of the webinar on the NIDA Meetings and Events page after the meeting.

Inquiries

Please direct all inquiries to:

Tamara M. Haegerich, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1185
Email: [email protected]

Janet Kuramoto-Crawford
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8856
Email: [email protected]